Recommended Global Infectious Diseases Webinars & Conferences

Europe & UK

Infection Prevention 2026, Spain Tuberculosis 2026, France Rare Diseases Congress 2026, Czech Republic INFECTIOUS DISEASES-2026, France Infection Congress 2026, UK

Asia Pacific & Middle East

Canada

Infection Congress 2026

About Conference

We are pleased to announce the 13th International Congress on Infectious Diseases, scheduled for April 16–17, 2026, in the historic and vibrant city of London, UK. With the central theme: "Infectious Diseases in a Changing World: Challenges, Progress, and Future Directions," this two-day event promises to be a powerful platform for learning, innovation, and global collaboration in the field of infectious diseases.

Infectious diseases continue to pose complex challenges worldwide—through outbreaks, pandemics, antimicrobial resistance, and the growing influence of climate change on disease transmission. This congress provides a timely opportunity for researchers, healthcare professionals, policymakers, pharmaceutical leaders, and public health practitioners to share expertise, drive innovation, and shape the future of infectious disease prevention and management.

Key Highlights:

Interactive Keynote Talks by global experts and pioneers in infectious disease research
Scientific Sessions & Poster Presentations covering virology, bacteriology, parasitology, immunology, epidemiology, vaccines, and more
Workshops & Panel Discussions on emerging technologies, diagnostics, global health strategy, and One Health approaches
Exhibition Opportunities for industry leaders and start-ups to showcase innovations
Networking Sessions for attendees to build collaborations and advance professional partnerships

Whether you are a seasoned professional or an early-career researcher, this congress is designed to inspire dialogue, spark discovery, and promote actionable solutions.

Submit Your Abstract

Present your ground breaking work to an international audience of peers, collaborators, and leaders. We welcome submissions from all areas of infectious disease research and practice.
1^st round Submission Deadline: [ August 28,2026 ]

Submit here: https://infectioncongress.infectiousconferences.com/abstract-submission.php

Register Today

Be part of this dynamic exchange of science and ideas. Enjoy early bird savings and secure your participation in one of 2026’s most anticipated infectious disease conferences.
Early Bird Registration Closes: [ August 28,2026 ]

Register here: https://infectioncongress.infectiousconferences.com/registration.php

Why Attend?

Stay updated with latest research trends and public health strategies
Connect with international experts and peers from over 40 countries
Explore career and academic growth opportunities
Discover new partnerships, products, and services from industry exhibitors
Experience London, a global city rich in culture, history, and innovation

Join us in London to explore the evolving landscape of infectious diseases and help shape a safer, healthier future.

Session & Tracks

1. Antimicrobial Resistance (AMR)

Antimicrobial resistance (AMR) is one of the most urgent threats to global health, food security, and development. Bacteria, viruses, fungi, and parasites are evolving to resist existing treatments, rendering common infections harder to treat and increasing the risk of disease spread, severe illness, and death. The overuse and misuse of antibiotics in humans and animals, coupled with poor infection prevention and control, have accelerated resistance globally. AMR not only endangers modern medicine but also undermines surgeries, cancer therapies, and intensive care treatments. At the conference, discussions around AMR will spotlight innovative diagnostics, global surveillance, policy frameworks, stewardship programs, and novel antimicrobial development. The session aims to promote international collaboration to slow resistance and preserve the effectiveness of existing drugs, making AMR a top priority on the infectious disease agenda.

2. Emerging Infectious Diseases

Emerging infectious diseases (EIDs) refer to infections that have recently appeared within a population or those whose incidence or geographic range is rapidly increasing. These diseases often arise from zoonotic spill over—transmission from animals to humans—and include examples like Ebola, SARS, MERS, COVID-19, and Mpox. Factors such as globalization, urbanization, climate change, and ecological disruption contribute to the emergence and re-emergence of these threats. Understanding pathogen evolution, early warning systems, and global cooperation is vital to predicting and containing outbreaks. At this congress, experts will present research on emerging pathogens, genomic surveillance, field investigations, and pandemic modelling to enhance preparedness. This session will foster awareness, international coordination, and capacity building for detecting and responding to novel infectious disease threats.

3. Zoonotic Diseases

Zoonotic diseases—those transmitted between animals and humans—account for over 60% of infectious diseases and 75% of emerging diseases worldwide. Examples include rabies, avian influenza, brucellosis, and more recently, COVID-19. These infections can spread through direct contact, consumption of contaminated food, or via vectors like ticks and mosquitoes. Urban encroachment into wildlife habitats, increased livestock-human interaction, and global trade have intensified zoonotic risk. Sessions at the congress will delve into the epidemiology of zoonoses, cross-species transmission, and strategies for integrated surveillance through the One Health lens. Highlighting case studies and cross-sectoral initiatives, the conference aims to build knowledge and partnerships to mitigate the growing burden of zoonotic diseases across human, animal, and environmental health domains.

Related Associations & Societies: One Health Commission (OHC) | World Organisation for Animal Health (WOAH) | Eco Health Alliance | Global One Health Initiative (GOHi) | Society for Tropical Medicine and Hygiene (ASTMH) | International Veterinary Vaccinology Network (IVVN)

4. Pandemic Preparedness

The COVID-19 pandemic served as a wake-up call for the world’s vulnerability to large-scale outbreaks. Pandemic preparedness refers to the strategic planning, resource mobilization, infrastructure development, and policy frameworks necessary to detect and contain emerging infectious threats before they spiral into global crises. Key components include early surveillance systems, global cooperation, stockpiles of medical supplies, vaccine and diagnostic readiness, and trained public health workforces. At this conference, pandemic preparedness will be a key focus, with discussions centred around national strategies, lessons from COVID-19 and other outbreaks, and the importance of equitable access to healthcare resources. This track will also explore simulation exercises, risk communication, and innovations in rapid response to future pandemics—helping ensure that the global community is not caught unprepared again.

5. Vaccine Development

Vaccines remain one of the most effective tools for preventing infectious diseases. From smallpox eradication to the rapid deployment of COVID-19 vaccines, immunization has saved millions of lives. Today, researchers are leveraging technologies such as mRNA platforms, viral vectors, and protein subunits to develop faster, more adaptable vaccines against emerging and re-emerging pathogens. However, challenges remain—vaccine hesitancy, equitable distribution, cold chain logistics, and rapid variant evolution. This congress will feature discussions on the latest advances in vaccine science, including universal influenza vaccines, RSV immunization, and next-gen delivery systems. Experts will also explore policy frameworks for regulatory approval, public communication strategies, and pandemic-scale production. Attendees will gain insights into overcoming scientific, logistical, and societal hurdles to accelerate vaccine innovation and global coverage.

Related Associations & Societies: International Society for Vaccines (ISV) | Global Alliance for Vaccines and Immunization (GAVI) | European Vaccine Initiative (EVI) | Sabin Vaccine Institute | American Association of Immunologists (AAI) | International Union of Immunological Societies (IUIS)

6. Global Health Security

Global health security focuses on protecting populations from infectious disease threats, whether naturally occurring, accidental, or deliberate. As the COVID-19 pandemic demonstrated, diseases know no borders—and weaknesses in one country’s health system can have cascading global consequences. Global health security involves building robust surveillance networks, resilient healthcare infrastructure, rapid response capacity, and transparent international cooperation. It also requires investments in workforce training, laboratory systems, data sharing, and emergency communication. This session at the congress will emphasize the need for a unified global strategy, discussing WHO’s International Health Regulations (IHR), the Global Health Security Agenda (GHSA), and real-world examples of outbreak response coordination. Experts will explore how nations can collaborate to build preparedness and resilience, ensuring a healthier, safer world for all.

7. Climate Change and Infectious Diseases

Climate change is reshaping the epidemiology of infectious diseases. Rising temperatures, changing precipitation patterns, and extreme weather events are expanding the range of vectors like mosquitoes and ticks, contributing to the spread of Malaria, Dengue, Chikungunya, and Lyme disease. Waterborne diseases like Cholera and Leptospirosis also spike with floods and poor sanitation, while warmer conditions facilitate fungal pathogens like Candida auris. This session will examine how environmental shifts are influencing the emergence, transmission, and seasonality of infectious diseases. Topics include climate-sensitive disease modelling, ecological surveillance, and adaptive public health responses. By addressing the intersection of climate and disease, the congress will highlight the urgent need for integrated policies that support both planetary and human health.

8. Vector-Borne Diseases

Vector-borne diseases—transmitted by mosquitoes, ticks, fleas, and other vectors—are among the deadliest infectious threats globally. Malaria, dengue, Zika, chikungunya, yellow fever, and Lyme disease continue to impact millions, particularly in tropical and subtropical regions. Changes in climate, urbanization, and global travel have contributed to the spread of these diseases into previously unaffected areas. The conference will host sessions on vector ecology, vector control technologies (e.g., insecticide-treated nets, genetic modification), surveillance systems, and vaccine development efforts. Emphasis will also be placed on community education and environmental management. As these diseases transcend geographic and political boundaries, cross-border cooperation and evidence-based strategies are critical to their prevention and control.

9. One Health Approach

The One Health approach recognizes the interconnectedness of human, animal, and environmental health. It emphasizes that preventing and controlling infectious diseases requires collaborative, cross-disciplinary efforts involving physicians, veterinarians, ecologists, and public health professionals. Many infectious diseases—such as rabies, avian influenza, and brucellosis—are zoonotic, meaning they are transmitted between animals and humans. One Health promotes early detection, joint surveillance, shared data platforms, and integrated policy-making. This session will explore how the One Health framework is being applied globally to manage zoonotic risks, antimicrobial resistance, and ecosystem disruptions. By adopting this holistic strategy, we can better anticipate, detect, and respond to emerging health threats at the source.

10. Viral Infections and Outbreaks

Viral infections remain a major cause of global morbidity and mortality. From seasonal influenza and measles to deadly outbreaks like Ebola, SARS, and COVID-19, viruses continually challenge public health systems. These infections spread rapidly through populations and often require prompt detection, containment, and vaccination strategies. Advances in virology, genomics, and digital surveillance have improved our understanding and response capabilities—but challenges remain in resource-limited settings. This track will cover the virology, transmission dynamics, and control strategies of major viral infections, with case studies from recent outbreaks. Emphasis will be placed on early diagnostics, genomic sequencing, and international coordination in outbreak response. Attendees will explore how science and policy can work together to reduce the global burden of viral diseases.

11. Hospital-Acquired Infections (Nosocomial Infections)

Hospital-acquired infections (HAIs), also known as nosocomial infections, occur during a patient’s stay in a healthcare setting and are not present at the time of admission. Common HAIs include bloodstream infections, surgical site infections, urinary tract infections, and ventilator-associated pneumonia. These infections often result from invasive procedures, improper sterilization, or antibiotic resistance, and they contribute significantly to patient morbidity, longer hospital stays, and increased healthcare costs. This session will focus on infection control practices, antimicrobial stewardship, hand hygiene compliance, and the role of surveillance systems in identifying and mitigating HAIs. Discussions will also address innovations in hospital design, staff training, and technology-driven solutions like AI-assisted outbreak detection. Strengthening hospital infection control protocols is essential to improve patient safety and limit the spread of resistant pathogens.

12. COVID-19 Variants

Even after the initial pandemic wave, COVID-19 remains a dynamic global concern due to the emergence of new variants. Variants such as Delta, Omicron, and their sub-lineages have exhibited changes in transmissibility, immune escape, and disease severity. These mutations challenge vaccine efficacy and public health responses, highlighting the need for ongoing genomic surveillance and adaptive strategies. This session will cover the latest findings on SARS-CoV-2 evolution, global variant tracking, booster vaccine development, and long COVID impacts. Attendees will learn about how public health systems have adapted to the variant era and what lessons apply to future outbreaks. By understanding how COVID-19 continues to evolve, researchers and policymakers can refine strategies for response, treatment, and communication in a post-pandemic world.

13. Epidemiology and Public Health

Epidemiology—the study of disease patterns, causes, and effects in populations—is a foundational pillar of public health. Through surveillance, data analysis, and modeling, epidemiologists help identify outbreaks, track disease trends, and evaluate interventions. This session will explore how epidemiological methods guide decisions on vaccination campaigns, health education, and policy-making. Special focus will be given to modern tools such as real-time analytics, GIS mapping, and mobile data collection. The congress will also address the role of epidemiology in understanding disparities in disease burden and tailoring interventions for vulnerable communities. As public health continues to evolve, integrating robust epidemiological research with community engagement is key to creating responsive and equitable health systems.

14. Infection Prevention and Control (IPC)

Infection prevention and control (IPC) is critical for reducing the spread of infectious diseases in both healthcare and community settings. IPC includes protocols for hand hygiene, personal protective equipment (PPE), disinfection, waste management, and isolation procedures. These practices are especially vital in preventing outbreaks during pandemics or in high-risk environments such as intensive care units and nursing homes. At the congress, IPC experts will present on emerging global standards, outbreak containment strategies, staff training models, and the role of IPC in antimicrobial stewardship. Emphasis will also be placed on challenges in low-resource settings and innovations that make IPC scalable and sustainable. By strengthening IPC measures, we not only protect patients and health workers but also prevent the development and spread of resistant organisms.

15. Rapid Diagnostic Technologies

Timely and accurate diagnosis is key to controlling infectious diseases. Rapid diagnostic technologies have revolutionized early detection and disease management, especially in outbreak scenarios. Point-of-care tests, lateral flow assays, CRISPR-based diagnostics, and next-generation sequencing have enabled quicker identification of pathogens—even in remote or low-resource settings. These tools not only guide immediate clinical decisions but also inform public health surveillance. This session will highlight recent advancements in diagnostic platforms, their integration into surveillance systems, and challenges related to accessibility, cost, and regulation. Real-world case studies will demonstrate how rapid diagnostics have transformed responses to diseases like COVID-19, malaria, and tuberculosis. As innovation continues, ensuring equitable access and accuracy of these tools will be vital to global health success.

16. Multidrug-Resistant Tuberculosis (MDR-TB)

Multidrug-resistant tuberculosis (MDR-TB) poses a severe challenge to global TB elimination efforts. It occurs when Mycobacterium tuberculosis becomes resistant to at least isoniazid and rifampicin—the two most powerful first-line anti-TB drugs. MDR-TB requires longer, more expensive treatments with second-line drugs that often have stronger side effects. The burden is particularly high in low- and middle-income countries, compounded by poor adherence to treatment, weak healthcare infrastructure, and delayed diagnosis. At this congress, experts will address strategies for early detection using molecular diagnostics, shorter treatment regimens, and community-based support models. Discussions will also highlight the role of global partnerships and funding mechanisms like the Stop TB Partnership and Global Fund. Tackling MDR-TB requires a multi-pronged approach: improved diagnostics, patient-centred care, and robust health system strengthening.

17. Immunization Programs and Policies

Immunization is one of the most cost-effective public health interventions, preventing millions of deaths each year. However, maintaining high vaccination coverage and equitable access remains a challenge in many regions due to vaccine hesitancy, supply chain disruptions, and policy gaps. This session will explore the design and implementation of national immunization programs, the integration of new vaccines (e.g., HPV, RSV), and strategies to improve uptake in underserved populations. The discussion will also cover the role of digital registries, mobile health platforms, and school-based immunization initiatives. Special emphasis will be placed on lessons learned during COVID-19 vaccine rollouts and how they can strengthen routine immunization systems. With rising concerns over outbreaks of vaccine-preventable diseases like measles and polio, evidence-based policies and strong community engagement are more crucial than ever.

18. Neglected Tropical Diseases (NTDs)

Neglected tropical diseases (NTDs) affect more than one billion people globally, particularly in impoverished communities with limited access to healthcare, clean water, and sanitation. These diseases—such as leishmaniasis, schistosomiasis, lymphatic filariasis, onchocerciasis, and trachoma—cause chronic disability, social stigma, and economic hardship. Despite their impact, NTDs receive less attention and funding than other major diseases. This session will spotlight integrated control strategies such as mass drug administration, vector control, and community education. Experts will also highlight advances in diagnostics, treatment, and vaccine research. The congress aims to elevate NTDs on the global health agenda and advocate for collaborative, cross-sectoral interventions that align with the WHO’s 2030 roadmap to eliminate or control most NTDs. Addressing these diseases is not only a health priority but also a step toward health equity.

19. Disease Surveillance Systems

Disease surveillance is the cornerstone of outbreak detection and response. Effective surveillance systems enable early warning of emerging threats, monitor the burden of endemic diseases, and assess the impact of interventions. Modern surveillance includes both passive and active methods, often enhanced by digital tools like mobile data reporting, GIS mapping, and AI-driven analytics. Real-time genomic surveillance—especially during COVID-19—proved critical in tracking viral variants. This session will discuss the architecture of strong surveillance systems, data integration across human and animal health, and international cooperation through platforms like GISAID and GOARN. Case studies will illustrate how surveillance informed timely decisions during outbreaks such as mpox, Ebola, and cholera. Strengthening surveillance capacity is essential for building resilient health systems and achieving global health security.

20. Healthcare-Associated Infections (HAIs)

Healthcare-associated infections (HAIs) are infections patients acquire while receiving treatment for medical or surgical conditions. Common HAIs include catheter-associated urinary tract infections, surgical site infections, and ventilator-associated pneumonia. These infections are often linked to prolonged hospital stays, increased costs, and higher mortality—especially in immunocompromised patients. Preventing HAIs is a cornerstone of patient safety and quality healthcare. This session will explore evidence-based practices for infection control, including hand hygiene, environmental cleaning, device sterilization, and antimicrobial stewardship. The role of hospital leadership, staff training, and compliance monitoring will also be discussed. With the rise of antibiotic-resistant pathogens in healthcare environments, preventing HAIs is more important than ever. Participants will learn about surveillance tools, national benchmarking programs, and innovative technologies that are transforming infection prevention in clinical settings.

Market Analysis

1. Industry Overview

The global burden of infectious diseases continues to be a top concern in healthcare, especially with the recent emergence of diseases like COVID-19, Mpox, Ebola outbreaks, and avian influenza. The infectious diseases diagnostics market alone is expected to reach USD 40+ billion by 2026, while the antimicrobial resistance (AMR) market is seeing rapid growth due to the urgent need for new therapies, diagnostics, and stewardship programs. This reflects a robust demand for knowledge-sharing platforms like international conferences to unite academic, clinical, and industrial stakeholders.

2. Target Audience

The conference targets a diverse group of stakeholders:

Academia & Research: Microbiologists, virologists, Parasitologists, and infectious disease researchers
Healthcare Professionals: Infectious disease specialists, epidemiologists, clinicians, pharmacists, and nurses
Public Health Authorities: WHO, CDC, ECDC, national health ministries
Pharmaceutical & Biotech Companies: Vaccine developers, diagnostic manufacturers, and AMR-focused start-ups
Policy Makers & NGOs: Professionals involved in global health security and policy design
Students & Early Career Professionals: Those seeking research exposure and networking opportunities

3. Market Demand Drivers

Rising Threat of Emerging and Re-emerging Diseases: Zoonoses, climate-sensitive diseases, and global travel amplify risks
Antimicrobial Resistance (AMR): Predicted to cause 10 million deaths annually by 2050 if unchecked
Global Vaccine Development Boom: Accelerated by mRNA tech and pandemic preparedness needs
Climate Change: Expanding the geographic footprint of vector-borne diseases
Digital Health & Surveillance Innovation: Increasing investments in diagnostics, AI, and remote health monitoring

4. Competitive Landscape

While numerous infectious disease conferences are held globally, the 13th International Congress on Infectious Diseases stands out due to:

Timely and interdisciplinary theme: "Infectious Diseases in a Changing World: Challenges, Progress, and Future Directions"
Prestigious speaker line-up and abstract submissions
Strategic location in London—a global hub for research, biotech, and policy
Strong networking opportunities for academia–industry–policy collaboration

5. Regional Relevance

The UK and Europe remain at the forefront of infectious disease research, with institutions like the London School of Hygiene & Tropical Medicine, University of Oxford, and the European Centre for Disease Prevention and Control (ECDC) leading global initiatives. The region is also a hub for AMR initiatives and pandemic policy dialogues, making London an ideal host city.

6. Sponsorship and Exhibition Opportunities

With a projected attendance of 300–500 delegates from 40+ countries, the event offers branding opportunities for:

Pharma and biotech companies (vaccines, antimicrobials, diagnostics)
Research labs and publishers
Digital health and med-tech start-ups
NGOs and foundations supporting global health

7. Future Outlook

As the world braces for the next "Disease X," platforms that facilitate early-stage collaboration and evidence sharing are becoming indispensable. The 2026 Congress is well-positioned to serve as a critical convergence point for future-oriented solutions in infectious disease control and prevention.

To Collaborate Scientific Professionals around the World

Conference Date April 16-17, 2026

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Past Conference Report

Infection Congress 2025 Conference

Supported By

Journal of Infectious Diseases and Therap Journal of Infectious Diseases and Therapy Journal of Bacteriology and Parasitology

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Infectious Diseases

April 16-17, 2026 London, UK

Infectious Diseases in a Changing World: Challenges, Progress, and Future Directions

Conference Series Conferences gaining more Readers and Visitors